netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine

NEW YORK, NY, October 10, 2019—Research to Prevent Blindness (RPB) is pleased to announce that RPB Stein Innovation Awardee Gregg Semenza, MD, PhD, at Johns Hopkins University School of Medicine, has been named a winner of the 2019 Nobel Prize in Medicine. Dr. Semenza and two co-recipients—William G. Kaelin, Jr. of the Dana-Farber Cancer Institute and Sir Peter J. Ratcliffe of Oxford University—were selected as Nobel Laureates for “seminal discoveries… [revealing] the mechanism for one of life’s most essential adaptive processes,” namely, “how oxygen levels affect cellular metabolism and physiological function,” according to The Nobel Assembly at Karolinska Institutet. The work creates the potential for the development of new treatments for a host of diseases, including cancer, coronary artery disease, anemia, stroke and blinding eye diseases.

Nobel Laureate Dr. Gregg Semenza (right) and a colleague work in his lab at Johns Hopkins University School of Medicine. 

The work of all three Laureates builds upon each other to show that oxygen sensing is a vital function across many cell types. Specifically, Dr. Semenza discovered a protein complex that binds to a DNA segment in an oxygen-dependent manner, which he named hypoxia-inducible factor (HIF). When oxygen sensing in cells fails or is interrupted because HIF cannot properly bind to DNA, it can lead to disease in many different areas of the body, depending on which cells are affected.

Dr. Semenza, who is the C. Michael Armstrong Professor of Pediatrics, Medicine, Oncology, Radiation Oncology, Biological Chemistry, and Genetic Medicine, is using his RPB grant to apply and extend the knowledge gained during his Nobel Prize-winning work to eye diseases that are characterized by extraneous blood vessel growth, or angiogenesis.

“We and others have shown the critical role of HIF in stimulating angiogenesis in the eye. With support from RPB, we are now developing HIF inhibitors as a potential therapy for ocular disorders that are associated with neovascularization, such as wet age-related macular degeneration and diabetic retinopathy,” said Dr. Semenza.

“We are so proud of Dr. Semenza’s incredible research accomplishments and are thrilled that with an RPB grant, he is focusing his Nobel-caliber knowledge and skills on the development of treatments for blinding eye diseases,” said RPB President Brian Hofland, PhD.

Dr. Semenza will receive his Nobel Prize in December 2019 at a ceremony in Sweden. His RPB Stein Innovation Award is active through the end of 2020.

To learn more about Dr. Semenza’s Nobel Prize in Medicine, visit https://www.nobelprize.org/prizes/medicine/
To learn more about his ongoing research, visit  https://www.hopkinsmedicine.org/research/labs/gregg-semenza-lab.

About Research to Prevent Blindness

Research to Prevent Blindness (RPB) is the leading nonprofit organization supporting eye research directed at the prevention, treatment or eradication of all diseases that damage and destroy sight. As part of this purview, RPB also supports efforts to grow and sustain a robust and diverse vision research community. Since it was founded in 1960 by Dr. Jules Stein, RPB has awarded more than $368 million in research grants to the most talented vision scientists at the nation’s leading medical schools. As a result, RPB has been associated with nearly every major breakthrough in the understanding and treatment of vision loss in the past 50+ years. Learn more at www.rpbusa.org.

Related News: Diabetic Retinopathy, Feature Story, For the Media, Macular Degeneration, Top Story

scEYEnce campaign image

RPB and Partners Launch the scEYEnce Campaign

This new media campaign shines a spotlight on the powerful benefits of vision research.

Read More

 
David Williams

RPB and Association of University Professors of Ophthalmology Announce 2021 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

David Williams, PhD, is recognized for ground-breaking contributions to the field of vision research.

Read More

 
Michael Chiang

Former RPB Grantee Dr. Michael Chiang Named Director of National Eye Institute

Dr. Chiang is a respected scientist, clinician and leader in vision research.

Read More

 
RPB logo

Research to Prevent Blindness Expands Career Development Award

RPB is increasing both the amount of funding and the number of awards funded through its flagship grant in order to better support early-career vision scientists.

Read More

 
RPB logo

Research to Prevent Blindness and Allergan Foundation Announce New Partnership to Support Early-Career Vision Researchers

The organizations announce new grants to increase funding for innovative research from early-career vision scientists.

Read More

 
RPB logo
Watch The Video

Research to Prevent Blindness Celebrates 60th Anniversary

For the past 60 years, RPB has funded groundbreaking research to prevent, treat and cure all conditions that damage or destroy sight.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.